Recovery of Contrast Sensitivity After Descemet Membrane Endothelial Keratoplasty.


Journal

Cornea
ISSN: 1536-4798
Titre abrégé: Cornea
Pays: United States
ID NLM: 8216186

Informations de publication

Date de publication:
01 Sep 2021
Historique:
received: 26 06 2020
accepted: 01 01 2021
pubmed: 17 2 2021
medline: 15 12 2021
entrez: 16 2 2021
Statut: ppublish

Résumé

To study the change in contrast sensitivities in eyes with Fuchs endothelial dystrophy and bullous keratopathy after Descemet membrane endothelial keratoplasty (DMEK). In this prospective study, 50 pseudophakic eyes of 50 patients who received DMEK surgery at the Charité-Universitätsmedizin Berlin were included. Visual acuity; contrast sensitivity using OPTEC 6500 at spatial frequencies of 1.5, 3, 6, 12, and 18 cycles/degree in photopic and mesopic light with and without glare; central corneal thickness (CCT); and anterior and posterior corneal aberrations were measured preoperatively and at 3 and 12 months postoperatively. Best-corrected visual acuity (preoperative 0.67 ± 0.46 and after 12 months 0.19 ± 0.16 LogMAR, P < 0.001) and photopic and mesopic contrast sensitivities with and without glare improved significantly, whereas CCT decreased significantly (preoperative 677 ± 114 μm, after 12 months 527 ± 29 μm, P < 0.001). Preoperative CCT correlates significantly with preoperative photopic contrast sensitivity (correlation coefficient -0.462, P = 0.002), and postoperative total anterior aberrations correlates with postoperative photopic contrast sensitivity (correlation coefficient -0.361, P = 0.006). Photopic and mesopic contrast sensitivities, especially with glare, are impaired in patients with Fuchs endothelial dystrophy and bullous keratopathy. The extent of the corneal thickening seems to mainly influence the contrast sensitivity preoperatively. DMEK surgery improves the contrast sensitivity significantly. However, higher postoperative anterior corneal aberrations limit the postoperative contrast sensitivities.

Identifiants

pubmed: 33591041
doi: 10.1097/ICO.0000000000002686
pii: 00003226-202109000-00009
doi:

Banques de données

ClinicalTrials.gov
['NCT02020044']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1110-1116

Informations de copyright

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors have no funding or conflicts of interest to disclose.

Références

Singh A, Zarei-Ghanavati M, Avadhanam V, et al. Systematic review and meta-analysis of clinical outcomes of Descemet membrane endothelial keratoplasty versus Descemet stripping endothelial keratoplasty/Descemet stripping automated endothelial keratoplasty. Cornea. 2017;36:1437–1443.
Price DA, Kelley M, Price FW Jr, et al. Five-year graft survival of descemet membrane endothelial keratoplasty (EK) versus descemet stripping EK and the effect of donor sex matching. Ophthalmology. 2018;125:1508–1514.
Cursiefen C. Descemet membrane endothelial keratoplasty: the taming of the shrew. JAMA Ophthalmol. 2013;131:88–89.
Price MO, Gupta P, Lass J, et al. EK (DLEK, DSEK, DMEK): new Frontier in cornea surgery. Annu Rev Vis Sci. 2017;3:69–90.
Tourtas T, Laaser K, Bachmann BO, et al. Descemet membrane endothelial keratoplasty versus Descemet stripping automated endothelial keratoplasty. Am J Ophthalmol. 2012;153:1082–1090.
Maier AK, Gundlach E, Gonnermann J, et al. Retrospective contralateral study comparing Descemet membrane endothelial keratoplasty with Descemet stripping automated endothelial keratoplasty. Eye (Lond). 2015;29:327–332.
Cabrerizo J, Livny E, Musa FU, et al. Changes in color vision and contrast sensitivity after descemet membrane endothelial keratoplasty for Fuchs endothelial dystrophy. Cornea. 2014;33:1010–1015.
Satue M, Idoipe M, Gavin A, et al. Early changes in visual quality and corneal structure after DMEK: does DMEK approach optical quality of a healthy cornea? J Ophthalmol. 2018;2018:2012560.
Bayyoud T, Wilhelm H, Gelisken F, et al. Descemet membrane endothelial keratoplasty: development of contrast sensitivity and color vision in patients with fuchs endothelial corneal dystrophy. Cornea. 2020;39:841–845.
Garrido C, Cardona G, Güell JL, et al. Visual outcome of penetrating keratoplasty, deep anterior lamellar keratoplasty and Descemet membrane endothelial keratoplasty. J Optom. 2018;11:174–181.
Rudolph M, Laaser K, Bachmann BO, et al. Corneal higher-order aberrations after Descemet's membrane endothelial keratoplasty. Ophthalmology. 2012;119:528–535.
van Dijk K, Droutsas K, Hou J, et al. Optical quality of the cornea after Descemet membrane endothelial keratoplasty. Am J Ophthalmol. 2014;158:71–79.
Tase S, Shimizu T, Hayashi T, et al. Descemet's membrane endothelial keratoplasty for pseudoexfoliation syndrome: a case series. BMC Ophthalmol. 2019;19:119.
Hayashi T, Yamaguchi T, Yuda K, et al. Topographic characteristics after Descemet's membrane endothelial keratoplasty and Descemet's stripping automated endothelial keratoplasty. PLoS One. 2017;12:e0188832
Hohberger B, Laemmer R, Adler W, et al. Measuring contrast sensitivity in normal subjects with OPTEC 6500: influence of age and glare. Graefes Arch Clin Exp Ophthalmol. 2007;245:1805–1814.
Applegate R, Hilmantel G, Howland H. Area under the log contrast sensitivity function: a concise method of following changes in visual performance. OSA Tech Dig Ser. 1997;98–101.
Melles GR, Ong TS, Ververs B, et al. Descemet membrane endothelial keratoplasty (DMEK). Cornea. 2006;25:987–990.
Melles GR, Ong TS, Ververs B, et al. Preliminary clinical results of Descemet membrane endothelial keratoplasty. Am J Ophthalmol. 2008;145:222–227.
Maier AK, Gundlach E, Pilger D, et al. Rate and localization of graft detachment in Descemet membrane endothelial keratoplasty. Cornea. 2016;35:308–312.
Maier AK, Gundlach E, Schroeter J, et al. Influence of the difficulty of graft unfolding and attachment on the outcome in Descemet membrane endothelial keratoplasty. Graefes Arch Clin Exp Ophthalmol. 2015;253:895–900.
Kopplin LJ, Przepyszny K, Schmotzer B, et al. Relationship of Fuchs endothelial corneal dystrophy severity to central corneal thickness. Arch Ophthalmol. 2012;130:433–439.
Wacker K, McLaren JW, Kane KM, et al. Corneal optical changes associated with induced edema in Fuchs endothelial corneal dystrophy. Cornea. 2018;37:313–317.
Yamaguchi T, Negishi K, Yamaguchi K, et al. Effect of anterior and posterior corneal surface irregularity on vision after Descemet-stripping endothelial keratoplasty. J Cataract Refract Surg. 2009;35:688–694.
Morishige N, Yamada N, Teranishi S, et al. Detection of subepithelial fibrosis associated with corneal stromal edema by second harmonic generation imaging microscopy. Invest Ophthalmol Vis Sci. 2009;50:3145–3150.
Koh S, Maeda N, Nakagawa T, et al. Quality of vision in eyes after selective lamellar keratoplasty. Cornea. 2012;31(suppl 1):S45–S49.
Hindman HB, Huxlin KR, Pantanelli SM, et al. Post-DSAEK optical changes: a comprehensive prospective analysis on the role of ocular wavefront aberrations, haze, and corneal thickness. Cornea. 2013;32:1567–1577.
Yamaguchi T, Negishi K, Yamaguchi K, et al. Comparison of anterior and posterior corneal surface irregularity in Descemet stripping automated endothelial keratoplasty and penetrating keratoplasty. Cornea. 2010;29:1086–1090.

Auteurs

Enken Gundlach (E)

Department of Ophthalmology, Campus Virchow-Klinikum, Charité-University Medicine Berlin, Corporate Member of Freie Universität Berlin, Humboldt- Universität zu Berlin and Berlin Institute of Health, Berlin, Germany; and.

Daniel Pilger (D)

Department of Ophthalmology, Campus Virchow-Klinikum, Charité-University Medicine Berlin, Corporate Member of Freie Universität Berlin, Humboldt- Universität zu Berlin and Berlin Institute of Health, Berlin, Germany; and.

Tobias Brockmann (T)

Department of Ophthalmology, Universitätsmedizin Rostock, Berlin, Germany.

Tina Dietrich-Ntoukas (T)

Department of Ophthalmology, Campus Virchow-Klinikum, Charité-University Medicine Berlin, Corporate Member of Freie Universität Berlin, Humboldt- Universität zu Berlin and Berlin Institute of Health, Berlin, Germany; and.

Antonia M Joussen (AM)

Department of Ophthalmology, Campus Virchow-Klinikum, Charité-University Medicine Berlin, Corporate Member of Freie Universität Berlin, Humboldt- Universität zu Berlin and Berlin Institute of Health, Berlin, Germany; and.

Necip Torun (N)

Department of Ophthalmology, Campus Virchow-Klinikum, Charité-University Medicine Berlin, Corporate Member of Freie Universität Berlin, Humboldt- Universität zu Berlin and Berlin Institute of Health, Berlin, Germany; and.

Anna-Karina B Maier (AB)

Department of Ophthalmology, Campus Virchow-Klinikum, Charité-University Medicine Berlin, Corporate Member of Freie Universität Berlin, Humboldt- Universität zu Berlin and Berlin Institute of Health, Berlin, Germany; and.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH